King Pharmaceuticals LLC
King Pharmaceuticals LLC (United States) holds 0 active US FDA Type II Drug Master Files and 1 inactive. 41 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “King Pharmaceuticals LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/king-pharmaceuticals-llc
Overview
King Pharmaceuticals LLC is a subsidiary of Pfizer Inc., focusing on the development, manufacturing, and marketing of various pharmaceutical products. As part of Pfizer, one of the world's largest pharmaceutical companies, King Pharmaceuticals benefits from extensive resources and research capabilities.
Therapeutic areas
API / Drug Master Files
King Pharmaceuticals LLC holds 0 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BRISTOL, TENNESSEE.Inactive1990-12-27
FDA compliance signals
41 FDA enforcement records linked to this company.
- 4832025-02-18
Procedures for sterile drug products
- 4832025-02-18
Investigations of discrepancies, failures
- 4832025-02-18
Approve or reject components, products
- 4832025-02-18
Control procedures to monitor and validate performance
- 4832019-10-21
Procedures not in writing, fully followed
- 4832016-11-21
Written Procedures Not Followed
- 4832016-11-21
Establishment of time limitations
- 4832015-05-15
Procedures for sterile drug products
- 4832014-08-26
Training , Education , Experience overall
- 4832014-08-26
Cleaning / Sanitizing / Maintenance
- 4832014-08-26
Procedures not in writing, fully followed
- 4832014-08-26
Identification of persons involved, each significant step
- 4832014-08-26
Procedures for sterile drug products
- 4832012-12-13
Written record of investigation incomplete
- 4832012-12-13
Procedures not in writing, fully followed
- 4832012-12-13
Written procedures not established/followed
- 4832012-12-13
Equipment Design, Size and Location
- 4832012-12-13
Cleaning / Sanitizing / Maintenance
- 4832012-12-13
Written procedures fail to include
- 4832012-06-15
Procedures not in writing, fully followed
- 4832012-06-15
Establishment of time limitations
- 4832011-03-16
Written procedures fail to include
- 4832011-03-16
Scientifically sound laboratory controls
- 4832011-03-16
Extent of discrepancy, failure investigations
- 4832011-03-16
SOPs not followed / documented
- 4832011-03-16
Defined areas of adequate size for operations
- 4832011-03-16
Written procedures not established/followed
- 4832011-03-16
Testing Containers & Closures Conformity with Specs
- 4832011-03-16
Complaint Handling Procedure
- 4832011-03-16
Procedures not in writing, fully followed
- 4832010-01-19
Written procedures lacking for use of pesticides etc.
- 4832010-01-19
Buildings not maintained in good state of repair
- 4832010-01-19
Environmental Monitoring System
- 4832010-01-19
Procedures To Be in Writing
- 4832010-01-19
Written warehousing procedures established/followed
- 4832010-01-19
Second person sign off
- 4832010-01-19
Written procedures not established/followed
- 4832010-01-19
Procedures not in writing, fully followed
- 4832010-01-19
Buildings of Suitable Size, Construction, Location
- 4832010-01-19
Written record of investigation incomplete
- 4832008-11-25
Procedures are written, and followed
Is this King Pharmaceuticals LLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.